Hovione

Hovione is a pharmaceutical company that specializes in assisting pharmaceutical clients in bringing both new and off-patent drugs to market. The company is known for its ability to deliver solutions that are often hard to find elsewhere, thereby supporting its customers throughout the drug development process. Founded in 2015, Hovione also engages in venture capital through Hovione Capital, which focuses on early-stage life sciences investments across Europe. This venture arm primarily targets companies in the Therapeutics, MedTech, and Digital Health sectors, managing a portfolio that includes five companies, three located in Portugal and two in the UK. Hovione's dual focus on pharmaceutical services and venture capital positions it uniquely within the healthcare landscape.

Ricardo Henriques Ph.D

CEO

Past deals in Portugal

Delox

Seed Round in 2022
Delox is a company based in Cascais, Portugal, specializing in the design and development of bio-decontamination devices aimed at creating clean and safe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox focuses on non-toxic bio-decontamination solutions that effectively combat microorganisms. The company’s portfolio includes automatic biodecontamination robots tailored for various applications, such as sterilizing medical devices in hospitals and health centers, room decontamination in healthcare, pharmaceuticals, food industries, and even in space environments. Delox utilizes an innovative formulation of solid hydrogen peroxide, enhancing the efficiency and affordability of its bio-decontamination systems, which also serve laboratory equipment and humanitarian missions in challenging conditions.

CellmAbs

Seed Round in 2019
CellmAbs develops therapies for glycoimmunology and oncology. It offers solutions for cancer, immunotherapies, and glycobiology. The company is based in Lisbon, Portugal.

Delox

Seed Round in 2018
Delox is a company based in Cascais, Portugal, specializing in the design and development of bio-decontamination devices aimed at creating clean and safe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox focuses on non-toxic bio-decontamination solutions that effectively combat microorganisms. The company’s portfolio includes automatic biodecontamination robots tailored for various applications, such as sterilizing medical devices in hospitals and health centers, room decontamination in healthcare, pharmaceuticals, food industries, and even in space environments. Delox utilizes an innovative formulation of solid hydrogen peroxide, enhancing the efficiency and affordability of its bio-decontamination systems, which also serve laboratory equipment and humanitarian missions in challenging conditions.

Anybrain

Seed Round in 2015
Anybrain is a artificial intelligence and data processing firm.